Harpoon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Harpoon Therapeutics

11/08/2022 13:00

* Harpoon Therapeutics Inc  HARP.OQ  reported a quarterly
adjusted
loss of 53 cents​​ per share for the quarter ended in June. The
mean expectation of nine analysts for the quarter was for a loss
of 56 cents per share.
    * Revenue rose 42.2% to $8.30 million from a year ago;
analysts
expected $6.96 million. 
    * Harpoon Therapeutics Inc's reported EPS for the quarter
was a
loss of 53 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Harpoon Therapeutics Inc shares had risen by 13.1% this
quarter and lost 71.4% so far this year.
    * The company reported a quarterly loss of $17.35 million.
    * Wall Street's median 12-month price target for Harpoon
Therapeutics Inc is $10.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 12:00 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.56          -0.53          Beat
 Mar. 31 2022      -0.55          -0.62          Missed
 Dec. 31 2021      -0.42          -0.66          Missed
 Sep. 30 2021      -0.52          -0.51          Beat